European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Antioxidant, hypolipidemic, and anti-angiotensin-1-converting enzyme properties of lemon (Citrus limon) and lime (Citrus aurantifolia) juices

Oboh, G., Bello, F. O., Ademosun, A. O., Akinyemi, A. J., & Adewuni, T. M. (2015) · Comparative Clinical Pathology · doi:10.1007/s00580-015-2088-x · Cited by 45

Introduction to conceptual explorations on person-centered medicine

Mezzich, J. E., Snædal, J., van Weel, C., & Heath, I. (2010) · International Journal of Integrated Care · doi:10.5334/ijic.472 · Cited by 45

Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age

Scheltens, T., Verschuren, W. M. M., Boshuizen, H. C., Hoes, A. W., Zuithoff, N. P. A., Bots, M. L., & Grobbee, D. E. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283063a65 · Cited by 45

Are social relations less health protective in women than in men? Social relations, gender, and cardiovascular health

Orth‐Gomér, K. (2009) · Journal of Social and Personal Relationships · doi:10.1177/0265407509105522 · Cited by 46

Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction

Wald, D. S., Bangash, F., & Bestwick, J. P. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.01.014 · Cited by 44

Effects of caponisation on lipid and fatty acid composition of intramuscular and abdominal fat of medium-growth broilers

Sinanoglou, V. J., Mantis, F., Miniadis‐Meimaroglou, S., Symeon, G. K., & Bizelis, I. (2011) · British Poultry Science · doi:10.1080/00071668.2011.581269 · Cited by 44

Influence of chronic exercise on carotid atherosclerosis in marathon runners

Taylor, B. A., Zaleski, A. L., Capizzi, J. A., Ballard, K. D., Troyanos, C., Baggish, A. L., d’Hemecourt, P. A., Dada, M. R., & Thompson, P. D. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004498 · Cited by 44

Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study

Kheirandish, M., Asgari, S., Lotfaliany, M., Bozorgmanesh, M., Saadat, N., Tohidi, M., Azizi, F., & Hadaegh, F. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-20 · Cited by 44

Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities

Köenig, W., & Ridker, P. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq370 · Cited by 43

Cardiac rehabilitation after percutaneous coronary intervention: Results from a nationwide survey

Olsen, S. J., Schirmer, H., Bønaa, K. H., & Hanssen, T. A. (2017) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515117737766 · Cited by 44

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)

Kukharchuk, V. V., Владиславович, Е. М., Викторович, С. И., Arabidze, G. G., Балахонова, Т. В., Gurevich, V. S., Zelveyan, P. A., Murataliev, T. M., Myrzakhmetova, G., Александровна, С. О., et al. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-2-6-29 · Cited by 49

Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction

Robinson, J. G., & Davidson, M. H. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.4.461 · Cited by 44

Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication

Maahs, D. M., Ogden, L. G., Dabelea, D., Snell‐Bergeon, J. K., Daniels, S. R., Hamman, R. F., & Rewers, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1886-6 · Cited by 44

Why do women underestimate the risk of cardiac disease? A literature review

Hammond, J., Salamonson, Y., Davidson, P. M., Everett, B., & Andrew, S. (2007) · Australian Critical Care · doi:10.1016/j.aucc.2007.02.001 · Cited by 43

Incidence des accidents cardiovasculaires au cours de la maladie de Horton : résultats préliminaires de l'étude prospective en double cohorte GRACG

Page, L. L., Duhaut, P., Seydoux, D., et al. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.10.009 · Cited by 44

Comparación de las tablas REGICOR y SCORE para la clasificación del riesgo cardiovascular y la identificación de pacientes candidatos a tratamiento hipolipemiante o antihipertensivo

Buitrago, F., Cañón-Barroso, L., Herrera, N. D., Muro, E. C., Escobar-Fernández, M., & Serrano-Arias, J. M. (2007) · Revista Española de Cardiología · doi:10.1157/13099460 · Cited by 44

The role of self-efficacy in vascular risk factor management: A randomized controlled trial

Sol, B. G. M., van der Graaf, Y., van der Bijl, J. J., Goessens, B. M. B., & Visseren, F. L. J. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2007.12.005 · Cited by 44

EUROACTION: A European Society of Cardiology demonstration project in preventive cardiology.: A cluster randomised controlled trial of a multi-disciplinary preventive cardiology programme for coronary patients, asymptomatic high risk individuals and their families. Summary of design, methodology and outcomes

Wood, D. A. (2004) · European Heart Journal Supplements · doi:10.1093/eurheartj/6.suppl_j.j3 · Cited by 44

Screening patients for subclinical atherosclerosis with non-contrast cardiac CT

Ardehali, R., Nasir, K., Kolandaivelu, A., Budoff, M. J., & Blumenthal, R. S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.022 · Cited by 42

Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2

Santos, R. D., Waters, D. D., Tarasenko, L. C., Messig, M., Jukema, J. W., Ferrières, J., Verdejo, J., & Chiang, C.-W. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.08.009 · Cited by 43

Outcomes following a programme for lifestyle changes with people with hypertension

Drevenhorn, E., Kjellgren, K. I., & Bengtson, A. (2007) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2005.01493.x · Cited by 43

LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia

Brohet, C., Banai, S., ALINGS, A. M. W., Massaad, R., Davies, M. J., & Allen, C. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x382004 · Cited by 43

Triglyceride-Rich HDL3 from Patients with Familial Hypercholesterolemia Are Less Able to Inhibit Cytokine Release or to Promote Cholesterol Efflux

Ottestad, I. O., Halvorsen, B. L., Balstad, T. R., Otterdal, K., Borge, G. I. A., Brosstad, F. R., Myhre, A. M., Ose, L., Nenseter, M. S., & Holven, K. B. (2006) · Journal of Nutrition · doi:10.1093/jn/136.4.877 · Cited by 42

The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease

Windler, E. E. T., Schoeffauer, M., & Zyriax, B. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.032 · Cited by 43

Prevalence of self-reported hypertension and its relation to dietary habits, in adults; a nutrition & health survey in Greece

Pitsavos, C. S., Milias, G. A., Panagiotakos, D. B., Xenaki, D., Panagopoulos, G., & Stefanadis, C. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-206 · Cited by 43

Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals

Souza, A. B. D., Okawa, R. T. P., Silva, C. O., & Araújo, M. G. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1817-0 · Cited by 44

Adherence to Physical Activity Recommendations and Its Associated Factors: An Interregional Population-Based Study

Alkerwi, A., Schuh, B., Sauvageot, N., Zannad, F. M., Olivier, A., Guillaume, M., Albert, A., & Larsson, C. (2015) · Journal of Public Health Research · doi:10.4081/jphr.2015.406 · Cited by 44

Effectiveness of Nurse Based Motivational Interviewing for Smoking Cessation in High Risk Cardiovascular Outpatients: A Randomized Trial

Bredie, S. J. H., Fouwels, A., Wollersheim, H. C. H., & Schippers, G. M. (2010) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2010.06.003 · Cited by 42

Lipid-lowering agents for nephrotic syndrome

Kong, X., Yuan, H., Fan, J., Li, Z., Wu, T., & Jiang, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005425.pub2 · Cited by 42

Low‐dose aspirin promotes endothelial progenitor cell migration and adhesion and prevents senescence

Hu, Z., Zhang, F., Yang, Z., Zhang, J., Zhang, D., Yang, N., Zhang, Y., & Cao, K. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.03.004 · Cited by 42

Aspirin in the treatment of acute migraine attacks

Diener, H., Lampl, C., Reimnitz, P., & Voelker, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.4.563 · Cited by 43

Predictors of Masked Hypertension Among Treated Hypertensive Patients: An Interesting Association With Orthostatic Hypertension

Barochiner, J., Cuffaro, P. E., Aparicio, L. S., Alfie, J., Rada, M., Morales, M. S., Galarza, C. R., & Waisman, G. D. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt036 · Cited by 42

Secondary Medical Prevention among Danish Patients Hospitalised with Either Peripheral Arterial Disease or Myocardial Infarction

Gasse, C., Jacobsen, J. B., Larsen, A. C., Schmidt, E. B., Johannesen, N. L., Videbæk, J., Sørensen, H. T., & Johnsen, S. P. (2007) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2007.08.008 · Cited by 43

Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors

Haugnes, H. S., Aass, N., Fosså, S. D., Dahl, O., Klepp, O., Wist, E., Wilsgaard, T., & Bremnes, R. M. (2008) · Journal of Cancer Survivorship · doi:10.1007/s11764-008-0054-1 · Cited by 42

Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study

Geller, J. C., Caßens, S., Brosz, M., Keil, U., Bernarding, J., Kropf, S., Bierwirth, R., Lippmann-Grob, B., Schultheiss, H.-P., Schlüter, K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm520 · Cited by 42

Omega-3 fatty acids and cardiovascular disease

von Schacky, C. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200403000-00005 · Cited by 43

Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?

Harris, W. S. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0085-7 · Cited by 42

Statin therapy in the treatment of Alzheimer disease: what is the rationale?

DeKosky, S. T. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.006 · Cited by 43

A pilot-study to identify the feasibility of an Internet-based coaching programme for changing the vascular risk profile of high-risk patients

Goessens, B. M. B., Visseren, F. L. J., de Nooijer, J., van den Borne, H. W., Algra, A., Wierdsma, J., & van der Graaf, Y. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.06.004 · Cited by 40

Statin Prescribing in the Elderly in the Netherlands

Vooght, M. G.-D., der Zee, A. H. M., Schalekamp, T., Mantel-Teeuwisse, A. K., & Jansen, P. A. F. (2010) · Drugs & Aging · doi:10.2165/11537330-000000000-00000 · Cited by 41

Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease

Sabino, A. D. P., Fernandes, A. P., Lima, L. M., Ribeiro, D. D., Sousa, M. O., Santos, M. E. R. D. C., Mota, A. P. L., Dusse, L. M. S., & Ferriani, M. D. G. C. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0172-z · Cited by 40

Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas: a cross-sectional study

Ciccone, A., Proserpio, P., Roccatagliata, D. V., Nichelatti, M., Gigli, G. L., Parati, G., Lombardi, C., Pizza, F., Cirignotta, F., Santilli, I. M., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201643 · Cited by 41

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population

van Gils, P. F., Over, E. A. B., Reenen, H. H. H.-V., de Wit, G. A., van den Berg, M., Schuit, A. J., & Engelfriet, P. M. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000363 · Cited by 41

General Cardiovascular Risk Profile Identifies Advanced Coronary Artery Calcium and Is Improved by Family History

Scheuner, M. T., Setodji, C. M., Pankow, J. S., Blumenthal, R. S., & Keeler, E. B. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.894527 · Cited by 40

Development and validation of a risk prediction model for work disability: multicohort study

Airaksinen, J., Jokela, M. M., Virtanen, M., Oksanen, T., Pentti, J., Vahtera, J., Koskenvuo, M., Kawachi, I. I., Batty, G. D., & Mika Kivimaki, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-13892-1 · Cited by 46

Association of domain-specific physical activity and cardiorespiratory fitness with all-cause and cause-specific mortality in two population-based cohort studies

Bahls, M., Groß, S., Baumeister, S. E., Völzke, H., Gläser, S., Ewert, R., Markus, M. R. P., Medenwald, D., Kluttig, A., Felix, S. B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34468-7 · Cited by 42

Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme - rationale and design

Laucevičius, A., Kasiulevičius, V., Jatužis, D., et al. (2012) · Seminars in Cardiovascular Medicine · doi:10.2478/v10287-012-0003-3 · Cited by 41

Current European guidelines for management of arterial hypertension: Are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population

Pétursson, H., Getz, L., Sigurdsson, J. A., & Hetlevik, I. (2009) · BMC Family Practice · doi:10.1186/1471-2296-10-70 · Cited by 40

Observations, predictions and decisions--assessing cardiovascular risk assessment

Hense, H. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh118 · Cited by 39

Receptor activator of NF-κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability

Bertolotto, M. B., Lenglet, S., Vuilleumier, N., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0324 · Cited by 41

Effects of leisure-time physical activity on well-being among women: a 32-year perspective

Blomstrand, A., Björkelund, C., Ariai, N., et al. (2009) · Scandinavian Journal of Public Health · doi:10.1177/1403494809341092 · Cited by 40

Risk factors and their interaction on chronic kidney disease: A multi-centre case control study in Taiwan

Su, S., Lin, C. S., Kao, S., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0065-x · Cited by 40

Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness

Huang, F., Yang, Z., Xu, B., Bi, Y., Xu, M., Xu, Y. H., Lu, J., Liu, Y., Dai, M., Zhou, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054628 · Cited by 40

Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects

Dorresteijn, J. A. N., Visseren, F. L. J., Ridker, P. M., Paynter, N. P., Wassink, A. M. J., Buring, J. E., van der Graaf, Y., & Cook, N. R. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr423 · Cited by 40

"Are my Laboratory Results Normal?" Considerations to be Made Concerning Reference Intervals and Decision Limits.

Ceriotti, F., & Henny, J. (2008) · PubMed Central · Cited by 40

Practice setting and secondary prevention of coronary artery disease

Jankowski, P., Czarnecka, D., Badacz, L., Bogacki, P., Dubiel, J. S., Grodecki, J., Grodzicki, T. K., Maciejewicz, J., Mirek-Bryniarska, E., Nessler, J. M., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65236 · Cited by 40

Modulating Effect of Diet on Alzheimer’s Disease

Fernández-Sanz, P., Ruiz-Gabarre, D., & García‐Escudero, V. (2019) · Diseases · doi:10.3390/diseases7010012 · Cited by 41

NHG-Standaard Cardiovasculair risicomanagement

Wiersma, T., Boukes, F., Geijer, R. M. M., & Goudswaard, A. N. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_6 · Cited by 40

Level of Unawareness and Management of Diabetes, Hypertension, and Dyslipidemia among Adults in Luxembourg: Findings from ORISCAV-LUX Study

Alkerwi, A., Pagny, S., Lair, M., Delagardelle, C., & Beissel, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057920 · Cited by 44

Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol

Pita‐Fernández, S., Pértega-Díaz, S., Valdés-Cañedo, F., Seijo-Bestilleiro, R., Seoane‐Pillado, T., Fernández-Rivera, C., Alonso-Hernández, Á., Lorenzo-Aguiar, D., López‐Calviño, B., & López–Muñiz, A. (2011) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-11-2 · Cited by 39

Multicomponent exercise program improves blood lipid profile and antioxidant capacity in older women

Carvalho, J., Marques, E. A., Ascensão, A. A. M. R., Magalhães, J., Marques, F., & Mota, J. A. P. S. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.05.020 · Cited by 40

Factors Contributing to Initial Weight Loss Among Adolescents with Polycystic Ovary Syndrome

Geier, L. M., Bekx, M. T., & Connor, E. L. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.06.008 · Cited by 40

Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome

Tziakas, D. N., Chalikias, G. K., Tentes, I. K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn382 · Cited by 40

Ethnic differences in SCORE cardiovascular risk in Oslo, Norway

Kumar, B., Selmer, R. M., Lindman, A. S., Tverdal, A., Falster, K., & Meyer, H. E. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b07 · Cited by 40

Inhibition of HMG-CoA reductase activity and cholesterol permeation through Caco-2 cells by caffeoylquinic acids from Vernonia condensata leaves

Arantes, A. A., Fale, P. L. V., Costa, L. C. B., Pacheco, R., Ascensão, L., & Serralheiro, M. L. (2016) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2016.05.008 · Cited by 42

The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study

van Lennep, H. W. O. R., Liem, A. H., Dunselman, P. H. J. M., Dallinga‐Thie, G. M., Zwinderman, A. H., & Jukema, J. W. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x273273 · Cited by 40

Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany

Bischoff, B., Silber, S., Richartz, B. M., Pieper, L., Klotsche, J., Wïttchen, H., & for the DETECT study-group (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0399-2 · Cited by 41

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)

Michel Komajda, N., Curtis, P. S., Markolf Hanefeld, E., Beck‐Nielsen, H., Pocock, S., Zambanini, A., Jones, N. P., Gomis, R., Home, P., & For The RECORD Study Group (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-10 · Cited by 40

Investigating cardiovascular risk reduction ? the Rosuvastatin GALAXY Programme?

Schuster, H., & Fox, J. C. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.5.1187 · Cited by 47

Comparación entre la tabla del SCORE y la función Framingham-REGICOR en la estimación del riesgo cardiovascular en una población urbana seguida durante 10 años

Buitrago, F., Cañón-Barroso, L., Herrera, N. D., Muro, E. C., Simón, B. B., & Sánchez, I. P. (2006) · Medicina Clínica · doi:10.1157/13092437 · Cited by 40

Very low LDL-C levels may safely provide additional clinical cardiovascular benefit: the evidence to date

McCormack, T., Dent, R., & Blagden, M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12881 · Cited by 39

A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2

Santos, R. D., Waters, D. D., Tarasenko, L., Messig, M., Jukema, J. W., Chiang, C.-W., Ferrieres, J., & Foody, J. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.052 · Cited by 39

Omega-3 Fatty Acids and Mortality Outcome in Patients With and Without Type 2 Diabetes After Myocardial Infarction: A Retrospective, Matched-Cohort Study

Poole, C., Halcox, J., Jenkins‐Jones, S., Carr, E., Schifflers, M., Ray, K. K., & Currie, C. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.11.008 · Cited by 40

The Effect of Loss of Excess Weight on the Metabolic Risk Factors after Bariatric Surgery in Morbidly and Super-Obese Patients

Wolf, A. M., & Beisiegel†, U. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9169-0 · Cited by 40

Statin utilization according to indication and age: A Danish cohort study on changing prescribing and purchasing behaviour

Wallach‐Kildemoes, H., Vass, M., Hendriksen, C., & Andersen, M. T. (2012) · Health Policy · doi:10.1016/j.healthpol.2012.08.008 · Cited by 37

Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population

Nikitin, A. G., Chistiakov, D. A., Minushkina, L. O., Zateyshchikov, D. A., & Nosikov, V. V. (2010) · Heart and Vessels · doi:10.1007/s00380-009-1159-9 · Cited by 40

Mediterranean lifestyle and cardiovascular disease prevention

Georgousopoulou, E. N., Mellor, D. D., Naumovski, N., Polychronopoulos, E., Tyrovolas, S., Piscopo, S., Valacchi, G., Anastasiou, F., Zeimbekis, A., Bountziouka, V. P., et al. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.03.11 · Cited by 40

Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background

Rezuş, E., Macovei, L. A., Burlui, A., Cardoneanu, A., & Rezuș, C. (2021) · Life · doi:10.3390/life11101042 · Cited by 41

N-Terminal Pro-Brain Natriuretic Peptide in Arterial Hypertension: A Valuable Prognostic Marker of Cardiovascular Events

Pedersen, F., Raymond, I. E., Kistorp, C., Sandgaard, N. C. F., Jacobsen, P. K., & Hildebrandt, P. R. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.04.015 · Cited by 38

May subclinical arterial disease help to better detect and treat high-risk asymptomatic individuals?

Simon, A. C., & Levenson, J. A. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000184407.20257.58 · Cited by 39

Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany

Hense, H., Koesters, E., Wellmann, J., Meisinger, C., Völzke, H., & Keil, U. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282feec66 · Cited by 37

Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes

Palanca, A., Castelblanco, E., Perpiñán, H., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.018 · Cited by 38

Steps per Day and Arterial Stiffness

Cavero‐Redondo, I., Tudor‐Locke, C., Álvarez‐Bueno, C., Cunha, P., Aguiar, E. J., & Martínez‐Vizcaíno, V. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11987 · Cited by 40

Concordancia de las escalas REGICOR y SCORE para la identificación del riesgo cardiovascular alto en la población española

Gil-Guillén, V. F., Orozco‐Beltrán, D., Maiques-Galan, A., et al. (2007) · Revista Española de Cardiología · doi:10.1157/13111236 · Cited by 38

n-3 PUFA in CVD: influence of cytokine polymorphism

von Schacky, C. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005411 · Cited by 38

The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease

Goessens, B. M. B., van der Graaf, Y., Olijhoek, J. K., & Visseren, F. L. J. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.09.015 · Cited by 36

Cardiovascular Biomarkers

Köenig, W. (2007) · Circulation · doi:10.1161/circulationaha.107.707984 · Cited by 38

The Role of C-reactive Protein in Patient Risk Stratification and Treatment

Arroyo‐Espliguero, R., Viana-Llamas, M. C., Silva, J. A., & y, P. A. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.49 · Cited by 41

Emergency Room Treatment of Hypertensive Crises.

Salkić, S., Brkić, S., Batić-Mujanović, O., et al. (2015) · PubMed · doi:10.5455/medarh.2015.69.302-306 · Cited by 37

Carotid intima‐media thickness and apolipoprotein B/apolipoprotein A‐I ratio in middle‐aged patients with Type 2 diabetes

Dahlén, E. M., Länne, T., Engvall, J. E., Lindström, T., Grodzinsky, E., Nyström, F. H., & Östgren, C. J. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02693.x · Cited by 37

Is prevention of Type-2 diabetes feasible and efficient in primary care?

Lauritzen, T., Borch‐Johnsen, K., & Sandbæk, A. (2007) · Primary care diabetes · doi:10.1016/j.pcd.2006.11.001 · Cited by 37

Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004–2015

Blais, J. E., Chan, E. W., Law, S. W. Y., Mok, M. T. C., Huang, D., Wong, I. C. K., & Siu, C. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.11.015 · Cited by 37

Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?

Li, Y., Sperrin, M., Belmonte, M., Pate, A., Ashcroft, D. M., & van Staa, T. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-47712-5 · Cited by 39

Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register

Eliasson, B., Eeg‐Olofsson, K., Cederholm, J., Nilsson, P. M., & Guðbjörnsdóttir, S. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.02.003 · Cited by 36

Achievement of Cardiometabolic Goals among Diabetic Patients in Spain. A Nationwide Population-Based Study

Vidal, B. N., Banegas, J. R., León-Muñoz, L. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061549 · Cited by 37

Protein–nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia

Maximov, V. D., Reukov, V. V., Barry, J., Cochrane, C., & Vertegel, A. A. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/26/265103 · Cited by 37

High cardiovascular risk in Spanish workers

Chaparro, M. Á. S., Bonacho, E. C., González‐Quintela, A., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.001 · Cited by 37

Early detection and management of the high-risk patient with elevated blood pressure

de la Sierra, A. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s930 · Cited by 35

Use of secondary preventive medications after the first attack of acute coronary syndrome

Salomaa, V. V., Pääkkönen, R., Hämäläinen, H., Niemi, M., & Klaukka, T. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000244573.10229.6e · Cited by 37

Non-invasive screening for coronary artery disease: calcium scoring

Erbel, R. M., Möhlenkamp, S., Kerkhoff, G., Budde, T., & Schmermund, A. (2007) · Heart · doi:10.1136/hrt.2005.071258 · Cited by 38

Committee and Task Force Reports: Youth and Families Task Force Report

James, S., Jordan, K., Lasser, J. S., et al. (1997) · PsycEXTRA Dataset · doi:10.1037/e413432005-005

Ethnic Minority Elderly: A Task Force Report of the American Psychiatric Association

Busse, E. W. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199524310-00013 · Cited by 1

Committee and Task Force Reports: Task Force on Aging

Carlson, H. M., & David, S. (2004) · PsycEXTRA Dataset · doi:10.1037/e373992004-024

Committee and Task Force News: Task Force on Students-at-Risk

Kaslow, F. W., & Olson, D. L. (1991) · PsycEXTRA Dataset · doi:10.1037/e410102005-024 · Cited by 1

Update From the American Psychiatry Association's Task Force on Electroconvulsive Therapy

McDonald, W. M., Prudic, J., McCall, W. V., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.078 · Cited by 3